Standard Life Aberdeen »

Summit Therapeutics shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2024-09-30 $25M 1.1M 21.90

More positions owned by Standard Life Aberdeen

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Merck & Co (MRK)
Coca-Cola Company (KO)
Procter & Gamble Company (PG)

View all positions for Standard Life Aberdeen

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
BlackRock
BlackRock
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Jane Street
Susquehanna International
Citadel Advisors
Charles Schwab Investment Management
Standard Life Aberdeen
Darwin Global Management
Balyasny Asset Management
Northern Trust

View all funds holding Summit Therapeutics